HLB Therapeutics Co.,Ltd. HLB Therapeutics Co.,Ltd.

HLB Therapeutics Co.,Ltd.

115450

Rankning i aktier #18257
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Aktiekurs
$2.02
Marknadsvärde
$190.66M
Förändring (1 dag)
7.96%
Förändring (1 år)
-1.16%
Land
KR
Handel HLB Therapeutics Co.,Ltd. (115450)

Kategori

Healthcare
Historik för aktiesplit för HLB Therapeutics Co.,Ltd. (115450)
Aktien HLB Therapeutics Co.,Ltd. (symbol: 115450) har genomgått totalt 6 aktiesplitar.
Den senaste spliten skedde den Mar 12, 2026.
En 115450-aktie köpt före Dec 18, 2013 motsvarar nu 1.49754041325 115450-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
2026-03-12 21:20 x1.05 x1.49754041325
2025-01-14 21:20 x1.05 x1.426228965
2023-12-27 207:200 x1.035 x1.3583133
2023-03-15 2:1 x2 x1.31238
2022-12-28 207:400 x0.5175 x0.65619
2013-12-18 317:250 x1.268 x1.268
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
US
1 x3
AU
1 x100
BE
0 -
NL